The Work We Fund

Funded projects
1,320+
Men's Health Partners
20
Countries
20
We work closely with our global men's health partners to ensure collaboration, transparency and accountability for every project we fund. We monitor this through report cards which detail what we seek to achieve, key measures and the impact.
Prostate Cancer
"Together with the brightest minds in research, we aim to achieve significant breakthroughs in the hope of beating prostate cancer. Our disruptive funding approach identifies revolutionary ways to accelerate health outcomes by creating strong, global collaborative teams." Dr. Colleen Nelson, Global Scientific Chair.
Men's Health
"One Mo can help change the face of men’s health through the powerful conversations created globally during Movember. Men have the chance to confidently discuss men’s health with people around them, resulting in men taking action early, helping change and save lives." Paul Villanti, Executive Director, Programs
Mental health and suicide prevention
“The number of men taking their own lives around the world is one of the biggest challenges of our time. Movember is working to ensure all men and boys look after their mental health and are comfortable to seek help when they’re struggling.”
Brendan Maher, Global Director, Mental Health and Suicide Prevention.
Testicular Cancer
“Despite being the 2nd most common cancer in young men, testicular cancer is often a forgotten cancer due to early detection and treatment. Our projects look at underinvested areas such as improving access to healthcare services and treatment options for relapse” Paul Villanti, Executive Director, Programs.

Translation Acceleration Grant

Movember Funding to Date

Global funding AUD equivalent 21,723,000

What we seek to achieve

The goal of the Targeted Research Grants is to address a specific and pressing concern in prostate cancer research. Each program has focused on one field of study with the aim of validating the research and translating findings into policy or practice in the short term.

Country
Canada
Co-funded
Prostate Cancer Canada CAD 1,462,688; Distinguished Gentleman's Ride CAD 204,000; Ontario Institute for Cancer Research CAD 1,498,726
Implemented by
Prostate Cancer Canada
Project start date
April 2014
Project Status
Completed July 2016

About the project

By leveraging multidisciplinary collaboration, every TAG program aims to address a significant issue in the management of prostate cancer. There has been seven TAG programs:

•    TAG1 - Clinical validation on methods that will specifically and accurately distinguish between aggressive prostate cancers that need to be treated as opposed to more indolent forms of the disease.

•    TAG2 - Development of novel therapeutics and treatment options for metastatic and castrate resistant prostate cancer that have the potential to enter clinical trials within 5 years of the beginning of the funding period.

•    TAG3 / TrueNTH - Novel approaches focusing on the behavioural, physical, psychosocial, social/family, mental, functional, spiritual, emotional and practical concerns of men living with prostate cancer (Survivorship RFA), with the aim to influence clinical practice.

•    TAG4 - Development of novel intervention that can prevent disease progression and/or improve quality of life that have the potential to enter clinical trials within 5 years of the beginning of the funding period.

•    TAG5 - Development of intervention that can prevent disease progression to advanced disease and to better manage treatment resistance that can progress to a clinical or population study within 3 years.

•    TAG6 - Collaborative group-designed and execution of a national program that aims to advance the PSMA-targeted radionuclide therapy into clinical practice.

•    TAG7 - Clinical validation of existing putative biomarkers or tests in patient samples either through clinical trial or retrospectively analysis to enable more accurate and personalised selection of prostate cancer treatments.

•    TAG8 - Collaborative group-designed and execution of a national program that aims to demonstrate the clinical utility of PSMA-targeted PET imaging for men at risk of disease progression.

Prostate Cancer Research Alliance

The Program will fund research that leverages Australia's existing strengths in prostate cancer biomedical research to deliver outcomes that can be translated into clinical practice within the next 5 to 7 years.

Find out more
Australia
AUD 12,150,000
USA - Mass market, multi-platform public media documentary series & campaign

This project uses a mass market, multi dimensional campaigns to shift populations understanding, attitudes and intentions and ultimately improve health outcomes on a large scale. Focusing on Youth Mental Health we will be working in partnership with PBS to deliver a documentary series supported with educational, digital and in person elements delivered across the USA.

Find out more
United States
USD 2,400,000
Ironman Registry - ZAF

IRONMAN is an international, population-based registry of 5,000 men with advanced prostate cancer across ten countries. It seeks to understand clinical outcomes associated with management of advanced prostate cancer and understand the biological and clinical diversity of the disease.

Find out more
South Africa
Global Funding AUD equivalent 18,905,25
Ironman Registry - ESP

IRONMAN is an international, population-based registry of 5,000 men with advanced prostate cancer across ten countries. It seeks to understand clinical outcomes associated with management of advanced prostate cancer and understand the biological and clinical diversity of the disease.

Find out more
Spain
Global Funding AUD equivalent 18,905,25
Ironman Registry - IRL

IRONMAN is an international, population-based registry of 5,000 men with advanced prostate cancer across ten countries. It seeks to understand clinical outcomes associated with management of advanced prostate cancer and understand the biological and clinical diversity of the disease.

Find out more
Ireland
Global Funding AUD equivalent 18,905,25
Ironman Registry - CHE

IRONMAN is an international, population-based registry of 5,000 men with advanced prostate cancer across ten countries. It seeks to understand clinical outcomes associated with management of advanced prostate cancer and understand the biological and clinical diversity of the disease.

Find out more
Switzerland
Global Funding AUD equivalent 18,905,25
Ironman Registry - SWE

IRONMAN is an international, population-based registry of 5,000 men with advanced prostate cancer across ten countries. It seeks to understand clinical outcomes associated with management of advanced prostate cancer and understand the biological and clinical diversity of the disease.

Find out more
Sweden
Global Funding AUD equivalent 18,905,25
Ironman Registry - USA

IRONMAN is an international, population-based registry of 5,000 men with advanced prostate cancer across ten countries. It seeks to understand clinical outcomes associated with management of advanced prostate cancer and understand the biological and clinical diversity of the disease.

Find out more
United States
Global Funding AUD equivalent 18,905,25
Ironman Registry - GBR

IRONMAN is an international, population-based registry of 5,000 men with advanced prostate cancer across ten countries. It seeks to understand clinical outcomes associated with management of advanced prostate cancer and understand the biological and clinical diversity of the disease.

Find out more
United Kingdom
Global Funding AUD equivalent 18,905,25
Ironman Registry - CAN

IRONMAN is an international, population-based registry of 5,000 men with advanced prostate cancer across 15 countries. It seeks to understand clinical outcomes associated with management of advanced prostate cancer and understand the biological and clinical diversity of the disease.

Find out more
Canada
Global Funding AUD equivalent 18,905,25
Ironman Registry - AUS

IRONMAN is an international, population-based registry of 5,000 men with advanced prostate cancer across 15 countries. It seeks to understand clinical outcomes associated with management of advanced prostate cancer and understand the biological and clinical diversity of the disease.

Find out more
Australia
Global Funding AUD equivalent 18,905,25
Movember – Distinguished Gentleman’s Ride Clinician Scientist Award - 2017

Clinician Scientist Awards aim to support outstanding, clinically qualified professionals who have gained a PhD in health research, to combine their clinical career with a research career and establish themselves as independent researchers in the field of prostate cancer.

Find out more
Australia
-
TrueNTH Global Registry - AUS

Established in 2017 and operating across 17 countries, the TrueNTH Global Registry is an international project that aims to improve the physical and mental health of men with prostate cancer. Clinicians and hospitals contributing data to TrueNTH Global Registry receive regular, risk-adjusted reports on their patients’ health outcomes as compared to other clinicians and hospitals globally. This will support improvement in clinical practice and patient outcomes over time.

Find out more
Australia
Global funding AUD equivalent 20,336,828
Canadian Men's Health & Wellbeing Innovation Challenge

To support the implementation of outside the box proof of concept ideas that disrupt long held assumptions/myths about men and their health which will encourage doing things differently and ultimately lead to improved health outcomes.

Find out more
Canada
CAD 1,923,149
Prostate Cancer Outcomes - Registry Australia and New Zealand

The Prostate Cancer Outcomes Registry of Australia and New Zealand (PCOR-ANZ) is a clinical quality registry collecting data on the diagnosis, clinical care and outcomes for men living with prostate cancer across Australia and New Zealand.

Find out more
Australia
Global funding AUD equivalent 22,397,860
Nuts & Bolts

Nuts & Bolts is a website, optimised for mobile devices, that aims to bring resources to men who are facing a diagnosis of early stage testicular cancer. Using the principles of user-centred design, we have created a resource that delivers curated, relevant, and timely information to help men navigate their testicular cancer journey, from diagnosis and treatment to life after treatment.

Find out more
Australia
AUD 1,180,594
>
Page 1 of 33